1-3 of 3
Hy Levitsky
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel, Universal Targeting Receptor-Adaptor CAR Platform Demonstrates Versatile, Flexible, and Controlled Tumor Inhibition in an Ipsc-Derived T-Cell

Andrew Devaney, Jill Carton, Hunter Hoffman, Hillary J. Millar, David Walker, John Wheeler, Mike Miller, Chris Dower, Barry Morse, Hy Levitsky, Michael Naso
Journal: Blood
Blood (2024) 144 (Supplement 1): 7181.
https://doi.org/10.1182/blood-2024-210141
Published: 2024
Journal Articles

Leveraging Stage-Specific Promoters to Enhance Immune Cell Engineering in iPSC-Derived Cells for Cancer Immunotherapy

Arina Perez, Matthew S Hall, Sumei Lu, Brad Peterka, Michael Naso, Hy Levitsky, Buddha Gurung
Journal: Blood
Blood (2024) 144 (Supplement 1): 4820.
https://doi.org/10.1182/blood-2024-210942
Published: 2024
Journal Articles

Natural Killer and Gamma Delta T Cells Derived from Engineered Induced Pluripotent Stem Cells Have Potent Preclinical Activity to Treat B Cell-Mediated Autoimmune Diseases

Diana Chin, Andriana Lebid, Kaitlin Idank, Mark Mendonca, Arina Perez, Nicholas Alexander, Steven DeLuca, Charles Dominick, Buddha Gurung, Barry Morse, Liam Campion, Daniel Perry, Michael Naso, Hy Levitsky, Hillary Quinn
Journal: Blood
Blood (2024) 144 (Supplement 1): 3437.
https://doi.org/10.1182/blood-2024-210234
Published: 2024